National vaccine efforts need to fit global approach, says WHO

Bruce Aylward, International team lead for the WHO-China joint mission on COVID-19 coronavirus attends a news conference after his trip to China at the World Health Organization (WHO) in Geneva, Switzerland, 25 February, 2020. REUTERS/Denis Balibouse

GENEVA (Reuters) - National supply deals in the event of the development of a successful vaccine against the coronavirus should fit a global approach, World Health Organization senior adviser Bruce Aylward said on Tuesday.

World leaders pledged in late April to accelerate work on tests, drugs and vaccines against COVID-19 and to share them around the globe under a WHO-led initiative known as the ACT (Access to COVID-19 Tools) Accelerator.

More than 21.9 million people have been reported to be infected by the novel coronavirus globally and 772,647 have died, according to a Reuters tally.

Reporting by Stephanie Nebehay, Michael Shields and John Miller; Writing by Nick Macfie; Editing by Jon Boyle